RNA-based therapy in the management of lipid disorders: a review

This review focuses on antisense oligonucleotides and small interfering ribonucleic acid therapies approved or under development for the management of lipid disorders. Recent advances in RNA-based therapeutics allow tissue-specific targeting improving safety. Multiple potential target proteins have...

Descripción completa

Detalles Bibliográficos
Autores principales: Blom, Dirk Jacobus, Marais, Adrian David, Moodley, Rajen, van der Merwe, Nico, van Tonder, Alet, Raal, Frederick Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9034497/
https://www.ncbi.nlm.nih.gov/pubmed/35459248
http://dx.doi.org/10.1186/s12944-022-01649-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9034497/
https://www.ncbi.nlm.nih.gov/pubmed/35459248
http://dx.doi.org/10.1186/s12944-022-01649-3

Ejemplares similares